Welcome to Market Research Explore
MRE

Explore Market Research

Latest market research, industry analysis and market trend reports

Global Biologics and Biosimilars Market Analysis 2011-2017 and Forecast 2018-2023

Snapshot A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires. The global Biologics and Biosimilars market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biologics and Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Antibody Hormone Growth Factors Other Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.): Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck 3sbio Changchun High Tech CP Guojian Biotech Gelgen Innovent Dong Bao Ganlee United Laboratories Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): Tumor Diabetes Cardiovascular Hemophilia Others Region Coverage (Regional Output, Demand & Forecast by Countries etc.): North America Europe Asia-Pacific South America Middle East & Africa

Table of Content 1 Industry Overview 1.1 Biologics and Biosimilars Industry 1.1.1 Overview 1.1.2 Development of Biologics and Biosimilars 1.2 Market Segment 1.2.1 Upstream 1.2.2 Downstream 1.3 Cost Analysis 2 Industry Environment 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Biologics and Biosimilars Market by Type 3.1 Segment Overview 3.1.1 Antibody 3.1.2 Hormone 3.1.3 Growth Factors 3.1.4 Other 3.2 Market Size 3.3 Market Forecast 4 Major Companies List 4.1 Roche (Company Profile, Sales Data etc.) 4.2 Amgen (Company Profile, Sales Data etc.) 4.3 AbbVie (Company Profile, Sales Data etc.) 4.4 Sanofi-Aventis (Company Profile, Sales Data etc.) 4.5 Johnson & Johnson (Company Profile, Sales Data etc.) 4.6 Pfizer (Company Profile, Sales Data etc.) 4.7 Novo Nordisk (Company Profile, Sales Data etc.) 4.8 Eli Lilly (Company Profile, Sales Data etc.) 4.9 Novartis (Company Profile, Sales Data etc.) 4.10 Merck (Company Profile, Sales Data etc.) 4.11 3sbio (Company Profile, Sales Data etc.) 4.12 Changchun High Tech (Company Profile, Sales Data etc.) 4.13 CP Guojian (Company Profile, Sales Data etc.) 4.14 Biotech (Company Profile, Sales Data etc.) 4.15 Gelgen (Company Profile, Sales Data etc.) 4.16 Innovent (Company Profile, Sales Data etc.) 4.17 Dong Bao (Company Profile, Sales Data etc.) 4.18 Ganlee (Company Profile, Sales Data etc.) 4.19 United Laboratories (Company Profile, Sales Data etc.) 5 Market Competition 5.1 Company Competition 5.2 Regional Market by Company 6 Market Demand 6.1 Demand Situation 6.1.1 Demand in Tumor 6.1.2 Demand in Diabetes 6.1.3 Demand in Cardiovascular 6.1.4 Demand in Hemophilia 6.1.5 Demand in Others 6.2 Regional Demand Comparison 6.3 Demand Forecast 7 Region Operation 7.1 Regional Output 7.2 Regional Market 7.3 by Region 7.3.1 North America 7.3.1.1 Overview 7.3.1.2 by Country (U.S., Canada, Mexico) 7.3.2 Europe 7.3.2.1 Overview 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) 7.3.3 Asia-Pacific 7.3.3.1 Overview 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) 7.3.4 South America 7.3.4.1 Overview 7.3.4.2 by Country (Brazil, Argentina etc.) 7.3.5 Middle East & Africa 7.3.5.1 Overview 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) 7.4 Regional Forecast 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change 8.1.3 Manufacturers Gross Margin Analysis 8.2 Value Chain 8.3 Marketing Channel 9 Research Conclusion Table Upstream Segment of Biologics and Biosimilars Table Application Segment of Biologics and Biosimilars Table Global Biologics and Biosimilars Market 2012-2023, by Application, in USD Million Table Major Company List of Antibody Table Major Company List of Hormone Table Major Company List of Growth Factors Table Major Company List of Other Table Global Biologics and Biosimilars Market 2012-2017, by Type, in USD Million Table Global Biologics and Biosimilars Market 2012-2017, by Type, in Volume Table Global Biologics and Biosimilars Market Forecast 2017-2023, by Type, in USD Million Table Global Biologics and Biosimilars Market Forecast 2017-2023, by Type, in Volume Table Roche Overview List Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Amgen Overview List Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table AbbVie Overview List Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Sanofi-Aventis Overview List Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Johnson & Johnson Overview List Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Pfizer Overview List Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Novo Nordisk Overview List Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Eli Lilly Overview List Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Novartis Overview List Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Merck Overview List Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table 3sbio Overview List Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Changchun High Tech Overview List Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table CP Guojian Overview List Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Biotech Overview List Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Gelgen Overview List Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Innovent Overview List Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Dong Bao Overview List Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Ganlee Overview List Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table United Laboratories Overview List Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Global Biologics and Biosimilars Sales Revenue 2012-2017, by Company, in USD Million Table Global Biologics and Biosimilars Sales Revenue Share, by Company, in USD Million Table Global Biologics and Biosimilars Sales Volume 2012-2017, by Company, in Volume Table Global Biologics and Biosimilars Sales Volume Share 2012-2017, by Company, in Volume Table Biologics and Biosimilars Demand in Tumor, 2012-2017, in USD Million Table Biologics and Biosimilars Demand in Tumor, 2012-2017, in Volume Table Major Consumers Profile in Tumor Table Biologics and Biosimilars Demand in Diabetes, 2012-2017, in USD Million Table Biologics and Biosimilars Demand in Diabetes, 2012-2017, in Volume Table Major Consumers Profile in Diabetes Table Biologics and Biosimilars Demand in Cardiovascular, 2012-2017, in USD Million Table Biologics and Biosimilars Demand in Cardiovascular, 2012-2017, in Volume Table Major Consumers Profile in Cardiovascular Table Biologics and Biosimilars Demand in Hemophilia, 2012-2017, in USD Million Table Biologics and Biosimilars Demand in Hemophilia, 2012-2017, in Volume Table Major Consumers Profile in Hemophilia Table Biologics and Biosimilars Demand in Others, 2012-2017, in USD Million Table Biologics and Biosimilars Demand in Others, 2012-2017, in Volume Table Major Consumers Profile in Others Table Regional Demand Comparison List Table Major Application in Different Regions Table Biologics and Biosimilars Demand Forecast 2017-2023, by Application, in USD Million Table Biologics and Biosimilars Demand Forecast 2017-2023, by Application, in Volume Table Biologics and Biosimilars Output 2012-2017, by Region, in USD Million Table Biologics and Biosimilars Output 2012-2017, by Region, in Volume Table Global Biologics and Biosimilars Market 2012-2017, by Region, in USD Million Table Global Biologics and Biosimilars Market Share 2012-2017, by Region, in USD Million Table Global Biologics and Biosimilars Market 2012-2017, by Region, in Volume Table Global Biologics and Biosimilars Market Share 2012-2017, by Region, in Volume Table North America Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table North America Biologics and Biosimilars Market Size 2012-2017, by Country, in Volume Table Europe Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table Europe Biologics and Biosimilars Market Size 2012-2017, by Country, in Volume Table Asia-Pacific Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table Asia-Pacific Biologics and Biosimilars Market Size 2012-2017, by Country, in Volume Table South America Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table South America Biologics and Biosimilars Market Size 2012-2017, by Country, in Volume Table Middle East & Africa Biologics and Biosimilars Market Size 2012-2017, by Country, in USD Million Table Middle East & Africa Biologics and Biosimilars Market Size 2012-2017, by Country, in Volume Table Biologics and Biosimilars Market Forecast 2017-2023, by Region, in USD Million Table Biologics and Biosimilars Market Forecast 2017-2023, by Region, in Volume Table Price Factors List Table Notes of Part Source Table Methodology Introduction Figure Biologics and Biosimilars Industry Chain Structure Figure Global Biologics and Biosimilars Market Growth 2012-2017, by Type, in USD Million Figure Global Biologics and Biosimilars Market Growth 2012-2017, by Type, in Volume Figure North America Biologics and Biosimilars Market, by Company, in 2017 Figure Europe Biologics and Biosimilars Market Market, by Company, in 2017 Figure Asia-Pacific Biologics and Biosimilars Market Market, by Company, in 2017 Figure South America Biologics and Biosimilars Market Market, by Company, in 2017 Figure Middle East & Africa Biologics and Biosimilars Market Market, by Company, in 2017 Figure North America Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure North America Biologics and Biosimilars Market Size and Growth 2012-2017, in Volume Figure Europe Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure Europe Biologics and Biosimilars Market Size and Growth 2012-2017, in Volume Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2012-2017, in Volume Figure South America Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure South America Biologics and Biosimilars Market Size and Growth 2012-2017, in Volume Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2012-2017, in USD Million Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2012-2017, in Volume Figure Marketing Channels Overview


  Payment Mode
Single User $ 2980
Corporate User $ 5960

  About this Report
Category Healthcare
Published on 3/16/2017
Number of Pages 119
Over all Rating
"Rating is based on 128 reviews"